Calvin University

Calvin University, a private nonprofit educational institution based in Grand Rapids, Michigan, operates as a federal grant recipient across research and educational programs, with no federal contract prime or sub activity. The university holds 88 prime federal grants (90% of recent awards) and 10 grant sub-awards (10%), spanning a portfolio of $102 thousand in combined potential value across 98 total awards served by 30 distinct federal agencies since 2005.

The National Science Foundation anchors Calvin's federal footprint, accounting for 35 awards across multiple directorates. NSF funding supports basic and applied research including computational chemistry, cybersecurity education infrastructure, natural language processing for document revision, and geometric topology workshops. Representative NSF prime grants include a $290,646 Project Grant (CFDA 47.049) to develop analytical and computational tools for identifying chemical species in dynamic supramolecular assemblies, running through August 2028; a $163,803 award (CFDA 47.070) for the ESCALATE cybersecurity education platform and community hub, concluding June 2028; and a $175,000 award for interactive natural language technology to support writers in document structuring and revision. The Department of the Interior Fish and Wildlife Service Region 3 holds eight awards supporting environmental assessment research, including two cooperative agreements ($238,298 and $209,357) investigating contaminant effects on colonial waterbird populations and reproduction in Michigan Areas of Concern, with ultimate completion dates extending through September 2027 and September 2026.

The National Endowment for the Humanities (eight awards) and the Department of Education Office of Postsecondary Education (seven awards) round out Calvin's top four customer agencies by award count. NEH funded curriculum development and humanities renewal initiatives; the most recent Education grant was a $233,400 Project Grant (CFDA 84.042) for the TRIO Student Support Services program serving disadvantaged undergraduates. The National Institute of Allergy and Infectious Diseases (CFDA 93.855) awarded $450,764 on July 13, 2026, for research into mechanisms of HIV infection in resting CD4+ T cells stimulated by endothelial cells, running through June 2029. The Maternal and Child Health Bureau funded secondary data analysis of prenatal care initiation and birth outcomes (CFDA number not specified) as a $163,803 project grant.

Calvin's sub-award portfolio (10% of awards) includes collaborative positions under University of Michigan prime grants in biological and immunological research, sub-awards from the State of Michigan for environmental project management, participation in the Michigan Space Grant Consortium administered through the University of Michigan, and infrastructure roles under University of Texas at Austin's Natural Hazards Engineering Research Infrastructure platform. Two awards reach ultimate completion within the next twenty-four months, presenting minimal near-term recompete exposure. Activity accelerated in 2024 (eight awards) after flat years in 2022–2023, though 2025–2026 shows moderation to three to four awards annually, suggesting a consolidation of active research portfolios rather than portfolio expansion.